Eosinophil-induced prognosis improvement of solid tumors could be enabled by their vesicle-mediated barrier permeability induction

Medical Hypotheses

Volumn 70, Issue 3, 2008, Pages 582-584

  Mingomataj, Ervin Ç ^a  

^a Mother Theresa School of Medicine   (Albania)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ALLERGIC DISEASE; ANGIOGENESIS; ARTICLE; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; EOSINOPHIL; HUMAN; IMMUNOREGULATION; MEMBRANE VESICLE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; TISSUE INJURY; TUMOR NECROSIS;

CELL MEMBRANE PERMEABILITY; EOSINOPHILS; HUMANS; INFLAMMATION; NEOPLASMS; PROGNOSIS;

BACTERIA (MICROORGANISMS);

EID: 38849139739     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.06.017     Document Type: Article

References (26)

1. Egesten A., Calafat J., Janssen H., Knol E.F., Malm J., and Persson T. Granules of human eosinophilic leucocytes and their mobilisation. Clin Exp Allergy 31 (2001) 1173-1188
2. Munitz A., and Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 59 (2004) 268-275
3. Specht S., Saeftel M., Arndt M., et al. Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect Immun 74 (2006) 5236-5243
4. Lacy P., Weller P.F., and Moqbel R. A report from the international Eosinophil society: Eosinophils in a tug of war. J Allergy Clin Immunol 108 (2001) 895-900
5. Jacobsen E.A., Taranova A.G., Lee N.A., and Lee J.J. Eosinophils: singulary destructive effector cells or purveyors of immunoregulation?. J Aller Clin Immunol 119 (2007) 1313-1320
6. Stenfeldt A.L., and Wenneras C. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112 (2004) 605-614
7. Ramos A.L., Discipio R.G., and Ferreira A.M. Eosinophil cationic protein damages protoscoleces in vitro and is present in the hydatid cyst. Parasite Immunol 28 (2006) 347-355
8. Lee J.D., Tsai L.Y., Chen C.H., Wang J.J., Hsiao J.K., and Yen C.M. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop 97 (2006) 204-211
9. Yang P.C., Wang C.S., and An Z.Y. A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen. BMC Gastroenterol 5 (2005) 6
10. Tauro B. Eosinophilic synovitis. a new entity?. J Bone Joint Surg Br 77 (1995) 654-656
11. Lotfi R., Lee J.J., and Lotze M.T. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother 30 (2007) 16-28
12. Lowe D., Jorizzo J., and Hutt M.S. Tumor-associated eosinophilia: a review. Clin Pathol 34 (1981) 1343-1348
13. Takanami I., Takeuchi K., and Gika M. Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. Anticancer Res 22 (2002) 2391-2396
14. Cormier S.A., Taranova A.G., Bedient C., et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 79 (2006) 1131-1139
15. Scroggs M.W., Roggli V.L., Fraire A.E., and Sanfilippo F. Eosinophilic intracytoplasmic globules in pulmonary adenocarcinomas: a histochemical, immunohistochemical, and ultrastructural study of six cases. Hum Pathol 20 (1989) 845-849
16. Van Driel W.J., Kievit-Tyson P., van den Broek L.C., Zwinderman A.H., Trimbos B.J., and Fleuren G.J. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response. Gynecol Oncol 74 (1999) 188-195
17. Rothenberg M.E., Luster A.D., and Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92 (1995) 8960-8964
18. Di Carlo E., Modesti A., Coletti A., et al. Interaction between endothelial cells and the secreted cytokine drives the fate of an IL-4- or an IL-5-transduced tumour. J Pathol 186 (1998) 390-397
19. Tepper R.I., Pattengale P.K., and Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57 (1989) 503-512
20. Modesti A., Masuelli L., Modica A., et al. Ultrastuctural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma. Int J Cancer 53 (1993) 988-993
21. Pericle F., Giovarelli M., Colombo M.P., et al. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 153 (1994) 5659-5673
22. Noffz G., Qin Z., Kopf M., and Blankenstein T. Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors. J Immunol 160 (1998) 345-350
23. Mattes J., Hulett M., Xie W., et al. Immunotherapy of cytotoxic T-cell-resistant tumors by T-helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 197 (2003) 387-393
24. Ferreira A.M., Breijo M., Sim R.B., and Nieto A. Contribution of C5-mediated mechanisms to host defence against Echinococcus granulosus hydatid infection. Parasite Immunol 22 (2000) 445-453
25. Hogan S.P., Koskinen A., and Foster P.S. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 75 (1997) 284-288
26. Shinkai K., Mohrs M., and Locksley R.M. Helper T-cells regulate type-2 innate immunity in vivo. Nature 420 6917 (2002) 825-829